Ten years survival results of randomized study comparing weekly vs. triweekly cisplatin with concurrent radiation in locally advanced carcinoma cervix
R Nanda,
Aradhana Katke,
Thejaswini B
et al.
Abstract:Background
The current standard of treatment for locally advanced cervical cancer is concurrent chemo-radiation with improved overall survival (OS) by 6% with manageable toxicities. The cisplatin 40 mg/m
2
given weekly is the widely practiced regimen for 4–6 cycles concurrently with irradiation.
Materials and methods
Two hundred and twelve patients with histologically proven squamous cell carcinoma of cervix with stages IIB to IIIB were enroll… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.